Review: Potential of renin inhibition in cardiovascular disease
- 1 March 2003
- journal article
- Published by SAGE Publications in Journal of the Renin-Angiotensin-Aldosterone System
- Vol. 4 (1), 6-10
- https://doi.org/10.3317/jraas.2003.008
Abstract
Since renin catalyses the first and rate-limiting step of the renin-angiotensin system (RAS) cascade, interruption of the generation of angiotensin II (Ang II) by renin inhibitors at this highly specific initial step of the cascade has long been a therapeutic goal. The early development of renin inhibitors was hampered by problems with bioavailability and high costs of synthesis. However, more recently a potent non-peptidic inhibitor of renin, aliskiren, with acceptable oral bioavailability, has been synthesised. Aliskiren effectively reduces Ang II levels in normal volunteers and has been shown to lower blood pressure (BP) in patients with mild-to-moderate hypertension.Keywords
This publication has 53 references indexed in Scilit:
- Angiotensin II Suppression in Humans by the Orally Active Renin Inhibitor Aliskiren (SPP100)Hypertension, 2002
- Global Burden of Cardiovascular DiseasesCirculation, 2001
- β-blockers, angiotensin II, and ACE inhibitors in patients with heart failureThe Lancet, 2001
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureThe New England Journal of Medicine, 1999
- Metabolism of Angiotensin-(1–7) by Angiotensin-Converting EnzymeHypertension, 1998
- Angiotensin-(1–7) Augments Bradykinin-Induced Vasodilation by Competing With ACE and Releasing Nitric OxideHypertension, 1997
- Angiotensin-(1-7) Inhibits Vascular Smooth Muscle Cell GrowthHypertension, 1996
- Renal Circulation and Blockade of the Renin-Angiotensin SystemHypertension, 1995
- Effects of Blocking the Angiotensin II Receptor, Converting Enzyme, and Renin Activity on the Renal Hemodynamics of Normotensive Guinea PigsJournal of Cardiovascular Pharmacology, 1993
- Immediate blood pressure effects of the renin inhibitor enalkiren and the angiotensin-converting enzyme inhibitor enalaprilatAmerican Heart Journal, 1991